| Staff, Nathan P |
Mayo Clinic Rochester
United States |
Investigating the role of MAP2 in chemotherapy-induced peripheral neurotoxicity |
5R01CA275870-02 |
PAR-21-329 (R01 Clinical Trial Optional) |
Rachel Altshuler, Ph.D. |
| Ah, Diane Marie Von |
Ohio State University
United States |
Cognitive Training for Cancer-related Cognitive Impairment: A Multi-Center Randomized Controlled Trial |
5R01CA276222-02 |
|
Catherine Schweppe, Ph.D. |
| Atigadda, Venkatram Reddy |
University Of Alabama At Birmingham
United States |
Development of Potent and non-toxic rexinoids to prevent non-melanoma skin cancer |
5R01CA276683-02 |
|
Winfred Malone, Ph.D., M.P.H. |
| Huang, Ying |
Fred Hutchinson Cancer Center
United States |
Accelerating biomarker development through novel statistical methods for analyzing phase III/IV studies |
5R01CA277133-02 |
|
Nick Hodges, Ph.D. |
| Rosser, Charles J |
Cedars-Sinai Medical Center
United States |
A Multiplex Protein Biomarker-Based Immunoassay for the Early Detection of Bladder Cancer and its Implications in Tumor Biology |
5R01CA277810-02 |
|
Guillermo Marquez, Ph.D. |
| Mehrara, Babak J |
Sloan-Kettering Inst Can Research
United States |
Mechanisms of racial disparity in breast cancer-related lymphedema |
5R01CA278599-02 |
|
Ellen Richmond, M.S., G.N.P.-B.C. |
| Moscicki, Anna-Barbara |
University Of California Los Angeles
United States |
Real-world effectiveness of HPV vaccine in women living with HIV and its impact on cervical cancer screening accuracies |
5R01CA281293-02 |
|
|
| Rosenbluth, Jennifer M |
University Of California, San Francisco
United States |
In vitro models as a window to learn how to change outcomes in women at high risk of developing breast cancer |
5R01CA281361-02 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
| Boyer, Thomas G |
University Of Texas Hlth Science Center
United States |
Pathological reprogramming of the m6A epitranscriptome in uterine fibroids |
5R01HD106285-03 |
|
Goli Samimi, Ph.D., M.P.H. |
| Boyer, Thomas G |
University Of Texas Hlth Science Center
United States |
Pathological reprogramming of the m6A epitranscriptome in uterine fibroids |
5R01HD106285-03 |
|
Goli Samimi, Ph.D., M.P.H. |